Featured
The Untested Parachute: The FTC's Reclassification of Longevity Supplements and the Collapse of the Biohacking VC Boom
The FTC and FDA's reclassification of NAD+ and senolytic compounds as unapproved new drugs instantly deflates the $12 billion biohacking VC boom, forc...
Read Full Story →